GLOBUS MEDICAL (GMED) stock: insider trades, news & valuation
Heavy sellingShare price and insider trades
GLOBUS MEDICAL insider trading at a glance (Oct 9, 2026): in the past 12 months, 0 insiders bought $0 and 7 sold $17.5M of GMED stock on the open market.
Get emailed when insiders cluster-buy stocks like GMED
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
GMED insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | — | 0 | $4.4M | 2 |
| Q2 2026 | — | 0 | $2.0M | 1 |
| Q1 2026 | — | 0 | $3.3M | 4 |
| Q4 2025 | — | 0 | $7.8M | 7 |
Valuation, profit and volume
Summary
Over the past 12 months, 0 GLOBUS MEDICAL INC insiders reported open-market purchases totaling $0, while 7 insiders reported sales totaling $17.5M. 9 of 14 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Sep 16SEC | James R TobinDirector | Sell | 30,000 | $74.58 | $2.2M | +0.1% | — |
| Aug 19SEC | Stephen T ZarrilliDirector | Sell | 25,000 | $87.04 | $2.2M | -14.2% | — |
| Jun 9SEC | David D DavidarDirector | Sell | 25,000510,175 held (−5%) | $80.76 | $2.0M | -7.6% | — |
| Feb 27SEC | Kelly HullerEvp, Gc, Corporate Secretary | Sell Plan | 20,000 | $94.50 | $1.9M | -21.0% | — |
| Feb 17SEC | Kelly HullerEvp, Gc, Corporate Secretary | Sell Plan | 10,000 | $87.67 | $877K | -14.9% | — |
| Jan 12SEC | Kyle KlineCFO, President | Sell Plan | 3,594 | $101.10 | $363K | -26.2% | — |
| Jan 12SEC | Leslie V NorwalkDirector | Sell Plan | 2,00010,419 held (−16%) | $101.10 | $202K | -26.2% | — |
| Dec 16SEC | Leslie V NorwalkDirector | Sell Plan | 4,00012,419 held (−24%) | $88.85 | $355K | -16.0% | — |
| Dec 3SEC | Kyle KlineCFO, President | Sell Plan | 18,542 | $90.00 | $1.7M | -17.1% | — |
| Nov 28SEC | Kelly HullerSvp, Gc, Corporate Secretary | Sell Plan | 7,500 | $90.00 | $675K | -17.1% | — |
| Nov 13SEC | David D DavidarDirector | Sell | 25,000516,275 held (−5%) | $86.00 | $2.1M | -13.2% | — |
| Nov 13SEC | Stephen T ZarrilliDirector | Sell | 25,000 | $84.29 | $2.1M | -11.4% | — |
| Nov 10SEC | Ann D RhoadsDirector | Sell Plan | 8,00017,384 held (−32%) | $81.00 | $648K | -7.8% | — |
| Nov 10SEC | Ann D RhoadsDirector | Sell Plan | 2,00015,384 held (−12%) | $85.00 | $170K | -12.2% | — |
Insiders at GLOBUS MEDICAL INC
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Stephen T ZarrilliDirector | — | $4.3M | Aug 19, 2026 | — |
| David D DavidarDirector | — | $4.2M | Jun 9, 2026 | — |
| Kelly HullerEvp, Gc, Corporate Secretary | — | $3.4M | Feb 27, 2026 | — |
| James R TobinDirector | — | $2.2M | Sep 16, 2026 | — |
| Kyle KlineCFO, President | — | $2.0M | Jan 12, 2026 | — |
| Ann D RhoadsDirector | — | $818K | Nov 10, 2025 | — |
| Leslie V NorwalkDirector | — | $558K | Jan 12, 2026 | — |
GMED stock: common questions
Are GLOBUS MEDICAL INC insiders buying GMED stock?
In the past 12 months, 0 insiders reported open-market purchases of GMED worth $0.
Are GLOBUS MEDICAL INC insiders selling GMED stock?
7 insiders reported sales worth $17.5M over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is GMED's 52-week range?
Over the past year GMED has traded between $56.57 and $96.82. It last closed at $74.65 on Oct 9, 2026.